AZITHROMYCIN: MODERN PLACE OF THE DRUG IN THERAPY OF LOWER RESPIRATORY TRACTS INFECTIONS

• Main Authors: S. I. Sazhnova, N. A. Karoli, A. P. Rebrov
• Format: Article
• Language: Russian
• Published: Remedium Group LLC 2017-11-01
• Series: Медицинский совет
• Subjects: azithromycin; macrolides; lower respiratory tract infections; community-acquired pneumonia
• Online Access: https://www.med-sovet.pro/jour/article/view/2038

One of the important problems in pulmonology – lower respiratory tract infections that occupy a significant place in the structure of the pulmonary pathology. The major nosological entities at which this infection is the leading or the major ethiologic factor of the lower respiratory tract lesion is community-acquired pneumonia, exacerbations of the chronic obstructive lung disease, chronic bronchitis. The armamentarium of antibacterial drugs used for therapy of the lower respiratory tract infections azithromycin invariably retains leading positions. Depending on the nosological form it is used as the first line drug, an alternative drug or in a combination with other antibiotics. This is preconditioned by a number of exclusive peculiarities of azithromycin that makes it standing apart among other antibacterial drugs.